Prospective blinded randomised placebo controlled trial investigating whether oxycodone modified release reduces parenteral opioid use following intermediate thoracic surgery

ISRCTN ISRCTN14478115
DOI https://doi.org/10.1186/ISRCTN14478115
Protocol serial number 03-274
Sponsor Harefield Hospital (UK)
Funders Royal Brompton & Harefield NHS Trust fund the salaries., Napp Pharmaceuticals are supplying the study drugs and placebos.
Submission date
29/07/2004
Registration date
21/09/2004
Last edited
07/03/2017
Recruitment status
No longer recruiting
Overall study status
Completed
Condition category
Surgery
Prospectively registered
Protocol
Statistical analysis plan
Results
Individual participant data
Record updated in last year

Plain English summary of protocol

Not provided at time of registration

Contact information

Dr David Royston
Scientific

Department of Anaesthesia
Harefield Hospital
Hill End Road
Harefield
UB9 6JH
United Kingdom

Study information

Primary study designInterventional
Study designRandomised controlled trial
Secondary study designRandomised controlled trial
Scientific titleProspective blinded randomised placebo controlled trial investigating whether oxycodone modified release reduces parenteral opioid use following intermediate thoracic surgery
Study acronymOxyPATS
Study objectivesNot provided at time of registration
Ethics approval(s)Not provided at time of registration
Health condition(s) or problem(s) studiedPost-operative pain following intermediate thoracic surgery
InterventionOxycodone modified release 10 mg bd or placebo for 48 hrs postoperatively.
Intervention typeDrug
PhaseNot Specified
Drug / device / biological / vaccine name(s)Oxycodone
Primary outcome measure(s)

Not provided at time of registration

Key secondary outcome measure(s)

Not provided at time of registration

Completion date31/12/2005

Eligibility

Participant type(s)Patient
Age groupNot Specified
SexNot Specified
Key inclusion criteriaAdult patients scheduled for unilateral intermediate thoracic surgery (e.g. pleural abrasion, talc pleurodesis and lung biopsy)
Key exclusion criteriaNot provided at time of registration
Date of first enrolment01/01/2004
Date of final enrolment31/12/2005

Locations

Countries of recruitment

  • United Kingdom
  • England

Study participating centre

Department of Anaesthesia
Harefield
UB9 6JH
United Kingdom

Results and Publications

Individual participant data (IPD) Intention to shareNo
IPD sharing plan summaryNot provided at time of registration
IPD sharing plan

Editorial Notes

07/03/2017: No publications found in PubMed, verifying study status with principal investigator